Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Medical Device > Cardiovascular Device > Worldwide Heart Valve Market Report: 2009 Edition
Category
Medical Device (4395)
Cardiovascular Device (252)
Catheter Equipment (206)
CT and MRI and X ray (146)
Dental Equipment (177)
Disposable Medical Device (83)
Endoscopy Equipment (114)
Healthcare IT (310)
In Vitro Diagnostics Equipment (435)
Medical Imaging (425)
Molecular Imaging/Agents (29)
Nuclear Medical (76)
Ophthalmic Equipment (105)
Orthopedic (343)
Patient Monitoring (384)
Ultra Sound (50)
Wound Care (120)
Market Research Report

Worldwide Heart Valve Market Report: 2009 Edition

Published by Koncept Analytics
Published May, 2009 Product code 89654
Content info 32 pages
Price
US $ 800 PDF by E-mail (Single User License)
US $ 1600 PDF by E-mail (Corporate Use License)


Worldwide Heart Valve Market Report: 2009 Edition published by Koncept Analytics in May, 2009. This report consists of 32 pages and the price starts from US $ 800.

Introduction

Abstract

The two major segments of heart valve market - tissue valve & mechanical valve - both have pros and cons. Tissue valves have a lower risk for clotting but they are not durable for long-term usage compared to mechanical valves. Mechanical valves are more durable, but require anti-coagulant drugs to prevent blood clots. Tissue valve are ideal for older patients.

The mechanical valve market is expected to continue to grow in the low single digits while tissue valve market is growing at mid-single digit rates. Global mechanical valve unit sales have declined significantly over the last five years due to growth of tissue valves. Overall growth would be driven by the expansion of cardiac surgery in countries such as China, India and Eastern European nations.

Edwards Life Sciences is the leader in global tissue valve market while in the mechanical valve segment, St. Jude Medical is the global market leader. Heart valve companies are targeting the transcatheter valve segment, which presents an attractive market opportunity. The technology, involving less invasive approach, is ideal for high risk patients. In the long-term, transcatheter valves are expected to represent an increasing share of the heart valve market.

The report analyzes the heart valve market. It analyzes the worldwide and the US market. Apart from providing a competitive landscape of the market, the report also profiles the major companies, with a discussion of their key business strategies. It also analyzes the major product segments in the heart valve market.

By combining SPSS Inc.' s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Table of Contents

1. Heart Valves: An Overview

  • 1.1 Market Segments

2. Market Size

  • 2.1 Global Market Value
  • 2.2 Global Market Share
  • 2.3 Mechanical Valves
  • 2.4 Tissue Valves
  • 2.5 Valve Repair Segment
  • 2.6 US Market

3. Market Trends

  • 3.1 Low Penetration in Aortic Stenosis Market
  • 3.2 Opportunity in Transcatheter Valves
  • 3.3 Mitral Regurgitation
  • 3.4 Huge Expenditure on Cardiovascular Diseases
  • 3.5 Demographic Trends in Cardiovascular Diseases
  • 3.6 Stem Cells to Build New Heart Valves
  • 3.7 Significant Share of Untreated Patients

4. Company Profiles

  • 4.1 Medtronic
    • 4.1.1 Overview
    • 4.1.2 Business Strategies
    • 4.1.3 Diversification Strategy
    • 4.1.4 AF & Transcatheter Valve Business
    • 4.1.5 Marketing & Sales Strategy
  • 4.2 St. Jude Medical
    • 4.2.1 Overview
    • 4.2.2 Business Strategies
    • 4.2.3 Penetrating High-growth Segments of Medical Devices Market
    • 4.2.4 Robust AF Platform
  • 4.3 Edwards Lifesciences
    • 4.3.1 Overview
    • 4.3.2 Business Strategies
    • 4.3.3 Divestment of Non-core Assets
    • 4.3.4 Dual Path Strategy
    • 4.3.5 Trancatheter Valve Business
  • 4.4 Sorin Group
    • 4.4.1 Overview
    • 4.4.2 Business Strategies
    • 4.4.3 Robust Product Pipeline
    • 4.4.4 Financial Strength

5. Industry Outlook

  • 5.1 Market Forecast
  • 5.2 Forecast Methodology
    • 5.2.1 Dependent and Independent Variables
    • 5.2.2 Correlation Analysis
    • 5.2.3 Regression Analysis

List of Tables

  • US Heart Valve Market by Value (2005-12)
  • US Heart Valve Market by Volume (2005-12)
  • Estimated Direct/Indirect Costs of CVD/Stroke in US (2009E)
  • Dependent & Independent Variables (2002 - 2008)
  • Correlation Matrix
  • Model Summary - Coefficient of Determination
  • Regression Coefficients Output

List of Charts

  • Heart Valve Market Segmentation
  • Global Heart Valve Market (2006-08E)
  • Global Heart Valve Market Share (2006-10E)
  • Surgical Valve Repair & Replacement Sales - Worldwide Market Share (2003-08)
  • Global Mechanical Valves Market Share (2007-12E)
  • Global Tissue Valves Market Share (2007-12E)
  • Surgical Valve Repair & Replacement Sales - US Market Share (2008)
  • Surgical Valve Repair & Replacement Sales - Europe Market Share (2008)
  • Aortic Stenosis Prevalence in US by Age (2007)
  • Type of Aortic Stenosis Prevalence in US by Age (2007)
  • Mitral Regurgitation Analysis in US (2007)
  • Prevalence of Cardiovascular Diseases by Age/Gender in US (2006)
  • Cardiovascular Market in US - Treated/Untreated by Therapy (2007)
  • Medtronic - Revenue by Business Segment (2008)
  • St. Jude Medical - Revenue by Business Segment (2008)
  • Edwards Lifesciences - Revenue by Business Segment (2008)
  • Sorin - Revenue by Business Segment (2008)
  • Heart Valve Market Forecast (2009-11E)
Back to Top